vTv Therapeutics (VTVT) Non-Current Debt (2014 - 2023)

vTv Therapeutics (VTVT) has 10 years of Non-Current Debt data on file, last reported at $191000.0 in Q4 2023.

• For the quarter ending Q4 2023, Non-Current Debt fell 14.73% year-over-year to $191000.0; the trailing twelve-month figure through Dec 2023 stood at $191000.0 (down 14.73% YoY), and the FY2023 full-year result was $191000.0, down 14.73% from the prior year.
• Non-Current Debt eased to $191000.0 in Q4 2023, from $922000.0 in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $4.5 million in Q1 2021 to a low of $191000.0 in Q4 2023.
• A 5-year average of $2.0 million and a median of $1.8 million in 2019 frame the typical range for Non-Current Debt.
• Across the five-year window, Non-Current Debt plunged 88.43% in 2019 and soared 99.19% in 2020, its largest moves.
• Tracing VTVT's Non-Current Debt over 5 years: stood at $2.6 million in 2019, then advanced by 10.38% to $2.9 million in 2020, then tumbled by 56.04% to $1.3 million in 2021, then slumped by 82.25% to $224000.0 in 2022, then fell by 14.73% to $191000.0 in 2023.
• Business Quant data shows VTVT's Non-Current Debt at $191000.0 in Q4 2023, $922000.0 in Q1 2023, and $224000.0 in Q4 2022.